May - 2014
| Previous Next | Showing Journal 3 of 15 |
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary FibrosisThe Idiopathic Pulmonary Fibrosis Clinical Research Network New Eng J Med, 2014, May 18, 2014DOI: 10.1056/NEJMoa1401739 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease, one of the presentations of idiopathic interstitial pneumonia (IIP) with a 5-year survival of approximately 40%, worse than many malignancies. Unfortunately therapeutic options that improve...